Others

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DCC1884	Dwn-723-23	Novel Hsp70 agonist, showing no cellular toxicity and induced cellular stress response pathways More description
DCC1883	Dw-1350	Novel and potent leukotriene B(4) receptor antagonist More description
DCC1882	Dw10075	Novel potent and highly selective inhibitor of VEGFR, exhibiting antitumor activities both in vitro and in vivo. More description
DCC1881	Dv-7028 Hydrochloride	Potent and selective 5-HT 2A receptor antagonist More description
DCC1880	Dv-7028	Selective 5-HT2A receptor antagonist More description
DCC1879	Dutomycin	Anthracycline antibiotic from Streptomyces More description
DCC1878	Duocarmycin A	Irreversible DNA minor groove binding alkylating agent, disrupting the nucleic acid architecture and leading to tumor cell death More description
DCC1877	Du-34569 Maleate	Antiviral agent against influenza A, parainfluenza Sendai, coxsackie A21, and rhinovirus More description
DCC1876	Dtagv-1	Potent and selective degrader of mutant FKBP12F36V fusion proteins More description
DCC1875	Dt2216nc	Negative control for DT2216 More description
DCC1874	Dt-061	Novel potent and orally active activator of PP2A More description
DCC1873	Ds-sg-44	Agonist of S1P receptors More description
DCC1872	Dsr-98776	Novel selective mGlu5 receptor negative allosteric modulator (NAM) with potent antidepressant and antimanic activity More description
DCC1871	Dsm705	Novel potent Dihydroorotate Dehydrogenase (DHODH) inhibitor More description
DCC1869	Dsm-338	Novel Plasmodium falciparum Dihydroorotate Dehydrogenase (PfDHODH) Inhibitor (Pfalcip cells: 0.0018 μM) More description
DCC1868	Dshs00884	Non-toxic human papillomavirus E6 inhibitor More description
DCC1867	Dsba Inhibitor F1	Pathogen motility inhibitor of EcDsbA More description
DCC1866	Ds79932728	Novel Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease More description
DCC1865	Ds42450411	Novel potent orally active hepcidin production inhibitor More description
DCC1864	Ds-3801b Hydrochloride	Novel non-macrolide GPR38 agonist More description
DCC1863	Ds37571084	Novel and orally bioavailable PTHR1 antagonist More description
DCC1862	Ds28120313	Novel potent orally active hepcidin production inhibitor More description
DCC1861	Ds19161384	Novel selective PPARγ modulator, resulting in robust plasma glucose reductions with excellent DMPK profiles More description
DCC1860	Ds08210767	Novel potent PTHR1 antagonist More description
DCC1859	Drostanolone Propionate	Inhibitor of the growth of estrogen receptor-presenting breast cancers More description
DCC1858	Dropropizine	Oral non-opioid anti-tussive agent for treatment of cough More description
DCC1857	Dri-c91005	Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV More description
DCC1856	Dri-c23041	Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV More description
DCC1855	Dp-v-4	Novel Dual PROTAC for Simultaneous Degradation of EGFR and PARP More description
DCC1854	D-propargylglycine	Click chemistry tool molecule in probing peptidoglycan (PG) More description

Others

Customized Consultation X

Your information is safe with us. * Required Fields.